Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

GR-205171: A non-peptide neurokinin NK1 antagonist

June 7, 1996

ADIR reports piperazines with affinity for sigma-receptors

June 7, 1996

Botulinum toxin type A: Treatment of choice for idiopathic cervical dystonia

June 7, 1996

Connective Therapeutics' peptide vaccine trial results presented

June 7, 1996

CellPro and Northwestern University commence first BMT clinical trial in MS patients

June 7, 1996

Cytokine polypeptides described by Immunex

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Trials expected to begin on CoCensys' CCD-1042

June 7, 1996

Pfizer reports neuroleptics

June 7, 1996

Asahi Chem. claims sigma-receptor ligands

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
Evaxion shares data from characterization of EVX-04
BioWorld Science
Evaxion A/S has developed EVX-04, an AI-designed DNA vaccine encoding 1β endogenous retroviruses (ERVs)-derived antigenic fragments to induce broad...